Molecular Partners Ag (MOLN) Operating Expenses (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Operating Expenses for 7 consecutive years, with -$17166.8 the latest figure, recorded in Q1 2026.

• Quarterly Operating Expenses rose 4.38% year-over-year to -$17166.8 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$50.3 million (down 190.65% YoY) and the FY2025 annual result came in at -$50.3 million, down 190.66% from the prior year.
• Operating Expenses advanced to -$17166.8 in Q1 2026 per MOLN's latest filing, from -$50.2 million in the prior quarter.
• Over the last five years, Operating Expenses for MOLN reached as high as $76.9 million in Q4 2023 and fell as low as -$50.2 million in Q4 2025.
• A 5-year average of $7.1 million and a median of -$17953.9 in 2025 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2024 — Operating Expenses jumped 99.89% — and 2025, when it tumbled 190.46%.
• Year by year, Operating Expenses stood at $75.8 million in 2022, then rose by 1.4% to $76.9 million in 2023, then slipped by 27.76% to $55.5 million in 2024, then slumped by 190.46% to -$50.2 million in 2025, then jumped by 99.97% to -$17166.8 in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered -$17166.8, -$50.2 million, and -$15057.6 for Q1 2026, Q4 2025, and Q3 2025 respectively.